Validity and Reliability of the Turkish Version of the DSM-5 “Severity Measure for Agoraphobia—Child Age 11–17”

Amaç: Bu çalışmada DSM-5 Agorafobi Şiddet Ölçeği Çocuk Formunun Türkçe sürümünün güvenilirliği ve geçerliliğinin değerlendirmesi amaçlanmıştır.Yöntem: Araştırma grupları çocuk psikiyatri kliniğinde tedavi gören ve agorafobi tanısı alan 36 hasta ile ortaokul ve lise öğrencilerinden oluşan 100 sağlıklı gönüllüden oluşmaktadır. Değerlendirmede Agorafobi Şiddet Ölçeği Çocuk Formunun yanı sıra Çocukluk Çağı Anksiyete Tarama Ölçeği kullanılmıştır.Bulgular: Güvenilirlik analizlerinde Cronbach alfa iç tutarlılık katsayısı 0.929'dur. Test- yeniden test bağıntı katsayısı r=0.566 olarak hesaplanmıştır. Birlikte geçerlilikte Çocukluk Çağı Anksiyete Tarama Ölçeği ile yüksek düzeyde bağıntı göstermiştir. ROC analizinde eğri altında kalan alan 0.934'dür.Sonuç: Agorafobi Şiddet Ölçeği Çocuk Formunun Türkçe sürümünün hem klinik uygulamada hem araştırmalarda güvenilir ve geçerli biçimde kullanılabileceği gösterilmiştir

DSM-5 Agorafobi Şiddet Ölçeği Çocuk Formunun Türkçe güvenilirliği ve geçerliliği

Objective: This study aimed to assess the validity and reliability of the Turkish version of the DSM-5 “Severity Measure for Agoraphobia—Child Age 11–17”. Method: Study group consisted of 36 patients, who have been treated in a child psychiatry unit and diagnosed with agoraphobia, and 100 healthy volunteers who have been secondary and highschool students. For the assessment, the Screen for Childhood Anxiety and Related Emotional Disorders (SCARED) was used along with the DSM-5 “Severity Measure for Agoraphobia—Child Age 11–17”. Results: Regarding reliability analyses, Cronbach’s alpha internal consistency coefficient was calculated as 0.929. Test-retest correlation coefficient was 0.566. For concurrent validity, the measure showed a high correlation with the SCARED. In ROC analysis, area under ROC curve was calculated as 0.934. Conclusion: It was concluded that Turkish version of the DSM-5 “Severity Measure for Agoraphobia—Child Age 11–17” could be used as a valid and reliable tool both in clinical practice and for research purposes

PDF

___

1. American Psychiatric Association. Diagnostic and statistical manual of Mental Disorders (5th ed.). Washington D.C: American Pyschiatric Association 2013.
2. Doerfler LA, Connor DF, Volungis AM, Toscano PF Jr. Panic disorder in clinically referred children and adolescents. Child Psychiatry Hum Dev 2007; 38:57-71. [CrossRef]
3. Biederman J, Faraone SV, Marrs A, Moore P, Garcia J, Ablon S, Mick E, Gershon J, Kearns ME. Panic disorder and agoraphobia in consecutively referred children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36:214-223. [CrossRef]
4. Mondin TC, Konradt CE, Cardoso Tde A, Quevedo Lde A, Jansen K, Mattos LD, Pinheiro RT, Silva RA. Anxiety disorders in young people: a population-based study. Rev Bras Psiquiatr 2013; 35:347-352. [CrossRef]
5. Wittchen HU, Reed V, Kessler RC. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch Gen Psychiatry 1998; 55:1017-1024. [CrossRef]
6. Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, Huang B, Saha TD. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2006; 67:363-374. [CrossRef]
7. Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, He JP, Koretz D, McLaughlin KA, Petukhova M, Sampson NA, Zaslavsky AM, Merikangas KR. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry 2012; 69:372-380. [CrossRef]
8. Fifer SK, Mathias SD, Patrick DL, Mazonson PD, Lubeck DP, Buesching DP. Untreated anxiety among adult primary care patients in a health maintenance organization. Arch Gen Psychiatry 1994; 51:740-750. [CrossRef]
9. Keller MB, Hanks DL. Course and outcome in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17:551-570. [CrossRef]
10. http://www.psychiatry.org/practice/dsm/dsm5/onlineassessment-measures. Accessed date: March 6, 2017.
11. Möller EL, Majdandzic M, Craske MG, Bögels SM. Dimensional assessment of anxiety disorders in parents and children for DSM-5. Int J Methods Psychiatr Res 2014; 23:331-344. [CrossRef]
12. Tavsancil E. Measurement of Attitude and Data Analysis with SPSS. Ankara: Nobel Publishing Co, 2006. (Turkish)
13. Birmaher B, Brent DA, Chiapetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry 1999; 38:1230-1236. [CrossRef]
14. Cakmakci FK. Reliability and validity study of Screening for anxiety disorders in children. Residency Thesis, Kocaeli University Medical School, Kocaeli, 2004. (Turkish)
15. Koroglu E, Aydemir O, Turkcapar H. Research design, management, and supervision in psychiatry. Ankara: HYB Publishing, 2012. (Turkish)
16. Lebeau RT, Glenn DE, Hanover LN, Beesdo-Baum K, Wiitchen HU, Craske MG. A dimensional approach to measuring anxiety for DSM-5. Int J Methods Psychiatr Res 2012; 21:258-272. [CrossRef]
17. Baydur H, Eser E. Application: Psychometric analysis of life quality measures. Medical Richness 2006; 1:99-123. (Turkish)
18. Beesdo-Baum K, Klotsche J, Knappe S, Craske MG, Lebeau RT, Hoyer J, Strobel A, Pieper L, Wittchen HU. Psychometric properties of the dimensional anxiety scales for DSM-V in an unselected sample of German treatment seeking patients. Depress Anxiety 2012; 29:1014-1024. [CrossRef]